Patient-reported outcomes in a trial of exenatide and insulin glargine for the treatment of type 2 diabetes

2327-PUB: Real-World Patient-Reported Outcomes (PROs) with Insulin Glargine 300 U/ml (Gla-300) in Basal Bolus-Treated People with Type 2 Diabetes (T2DM): The MAGE Study

Diabetes ◽

10.2337/db19-2327-pub ◽

2019 ◽

Vol 68 (Supplement 1) ◽

pp. 2327-PUB ◽

Cited By ~ 1

Author(s):

ANN A. VERHAEGEN ◽

ANDRÉ SCHEEN ◽

KATHY C. ALEXANDRE ◽

JACQUES BRUHWYLER ◽

IDES M. COLIN

Keyword(s):

Type 2 Diabetes ◽

Insulin Glargine ◽

Real World ◽

Patient Reported ◽

Basal Bolus

Patient-Reported Outcomes with Insulin Glargine 300 U/mL in People with Type 2 Diabetes: The MAGE Multicenter Observational Study

Diabetes Therapy ◽

10.1007/s13300-020-00866-2 ◽

2020 ◽

Vol 11 (8) ◽

pp. 1835-1847

Author(s):

Ides M. Colin ◽

Kathy Alexandre ◽

Jacques Bruhwyler ◽

André Scheen ◽

Ann Verhaegen

Keyword(s):

Type 2 Diabetes ◽

Observational Study ◽

Insulin Glargine ◽

Multicenter Observational Study ◽

Patient-reported outcomes from a randomized, crossover trial comparing a pen injector with insulin degludec versus a pen injector with insulin glargine U100 in patients with type 2 diabetes

Current Medical Research and Opinion ◽

10.1080/03007995.2019.1605769 ◽

2019 ◽

Vol 35 (9) ◽

pp. 1623-1629 ◽

Cited By ~ 1

Author(s):

Mark L. Warren ◽

Meryl Brod ◽

Jonas Håkan-Bloch ◽

Thomas Sparre ◽

Louis B. Chaykin

Keyword(s):

Type 2 Diabetes ◽

Insulin Glargine ◽

Crossover Trial ◽

Insulin Degludec ◽

Randomized Crossover Trial ◽

Improving treatment satisfaction and other patient-reported outcomes in people with type 2 diabetes: the role of once-daily insulin glargine

Diabetes Obesity and Metabolism ◽

10.1111/j.1463-1326.2008.00871.x ◽

2008 ◽

Vol 10 (s2) ◽

pp. 50-65 ◽

Cited By ~ 24

Author(s):

C. Bradley ◽

C. J. B. Gilbride

Keyword(s):

Type 2 Diabetes ◽

Insulin Glargine ◽

Treatment Satisfaction ◽

Once Daily ◽

Daily Insulin ◽

Improved Patient-reported Outcomes with Insulin Degludec 200 U/ml (IDeg U200) versus Insulin Glargine in Insulin-naïve People with Type 2 Diabetes

Canadian Journal of Diabetes ◽

10.1016/j.jcjd.2012.07.347 ◽

2012 ◽

Vol 36 (5) ◽

pp. S41 ◽

Cited By ~ 2

Author(s):

Richard Bergenstal ◽

Anuj Bhargava ◽

Rajeev K. Jain ◽

Torsen E. Christensen ◽

Azhar Rana ◽

...

Keyword(s):

Type 2 Diabetes ◽

Insulin Glargine ◽

Insulin Degludec ◽

Patient-Reported Outcomes (PROs) for Insulin Degludec/Liraglutide (IDegLira) vs. Insulin Glargine (IGlar U100) as Add-On to Sodium-Glucose Co-Transporter-2 Inhibitor (SGLT2i) ± Oral Antidiabetic Drug (OAD) Therapy in Patients with Type 2 Diabetes (T2D)—DUAL IX Trial

Diabetes ◽

10.2337/db18-101-lb ◽

2018 ◽

Vol 67 (Supplement 1) ◽

pp. 101-LB

Author(s):

MERYL BROD ◽

LIANA K. BILLINGS ◽

ROBERT S. BUSCH ◽

STEWART HARRIS ◽

CRISTOBAL MORALES PORTILLO ◽

...

Keyword(s):

Type 2 Diabetes ◽

Insulin Glargine ◽

Insulin Degludec ◽

Antidiabetic Drug ◽

Oral Antidiabetic Drug ◽

Oral Antidiabetic ◽

Patient-reported Outcomes in Patients with Type 2 Diabetes Treated with Dulaglutide Added to Titrated Insulin Glargine (AWARD-9)

Clinical Therapeutics ◽

10.1016/j.clinthera.2017.10.002 ◽

2017 ◽

Vol 39 (11) ◽

pp. 2284-2295 ◽

Cited By ~ 4

Author(s):

Maria Yu ◽

Kate Van Brunt ◽

Zvonko Milicevic ◽

Oralee Varnado ◽

Kristina S. Boye

Keyword(s):

Type 2 Diabetes ◽

Insulin Glargine ◽

Evaluation of the impact of once weekly dulaglutide on patient-reported outcomes in Japanese patients with type 2 diabetes: comparisons with liraglutide, insulin glargine, and placebo in two randomized studies

Health and Quality of Life Outcomes ◽

10.1186/s12955-017-0696-7 ◽

2017 ◽

Vol 15 (1) ◽

Cited By ~ 3

Author(s):

Shuichi Suzuki ◽

Tomonori Oura ◽

Masakazu Takeuchi ◽

Kristina S. Boye

Keyword(s):

Type 2 Diabetes ◽

Insulin Glargine ◽

Japanese Patients ◽

Randomized Studies ◽

Patient Reported ◽

The Impact

Insulin Degludec 200 Units/mL Is Associated With Lower Injection Frequency and Improved Patient-Reported Outcomes Compared With Insulin Glargine 100 Units/mL in Patients With Type 2 Diabetes Requiring High-Dose Insulin

Clinical Diabetes ◽

10.2337/cd15-0058 ◽

2017 ◽

Vol 35 (2) ◽

pp. 90-95 ◽

Cited By ~ 9

Author(s):

Mark L. Warren ◽

Louis B. Chaykin ◽

Serge Jabbour ◽

Mae Sheikh-Ali ◽

Charlotte T. Hansen ◽

...

Keyword(s):

Type 2 Diabetes ◽

Insulin Glargine ◽

Insulin Degludec ◽

High Dose ◽

Injection Frequency ◽

Patient-Reported Outcomes following Initiation of Glucagon-Like Peptide-1 Receptor AgonistS (GLP–1RA) in PatientS with Type 2 Diabetes—PROGRESS-DIABETES Study

Diabetes ◽

10.2337/db18-1096-p ◽

2018 ◽

Vol 67 (Supplement 1) ◽

pp. 1096-P

Author(s):

RUTH E. BROWN ◽

ALEXANDER ABITBOL ◽

HARPREET S. BAJAJ ◽

HASNAIN KHANDWALA ◽

RONALD GOLDENBERG ◽

...

Keyword(s):

Type 2 Diabetes ◽

Receptor Agonists ◽

Patient Reported ◽

Glucagon Like Peptide ◽

Glucagon Like Peptide 1